The American Academy of Pediatrics (AAP) Committee on Drugs recently published a clinical report stating that many of the medications today are safe for breastfeeding. The AAP Committee on Drugs also stated that taking the drugs poses more benefits than the risk of possible harm to the babies. According to the American Academy of Pediatrics, mothers are “inappropriately advised”. They are told to either stop breastfeeding when taking medication or not to take medicine when breastfeeding.
Many women are in fact misguided. They decided not to breastfeed their children because they are taking medication. They are worried about the adverse effects of the drugs on their babies. What they do not know is that the benefits of breastfeeding far outweighs the danger of taking medications when breastfeeding. Many of the drugs today are safe for breastfeeding while the benefits of breastfeeding include short and long term health benefits for children. Children who are breastfed, for example, have low risk of infection, asthma and sudden infant death syndrome. Children who are breastfed also grow up healthier.
According to Food and Drug Administration’s Center for Drug Evaluation and Research, it is difficult to classify which drugs are safe for breastfeeding. This is because it is always a case to case basis. As such, it is a risk benefit decision. What they want to emphasize is that many of the drugs today are safe. More importantly the benefits of breastfeeding are something that every mother should consider. The report by the American Academy of Pediatrics (AAP) Committee on Drugs identified the drugs that may potentially harm breastfed children.
One in every ten children suffers from stuttering by the time they reach the age of four. These children are quite normal, according to the new Australian study. The study found that children who stutter are as normal as their peers. In fact, the study found that in general they are even better than their non-stuttering counterparts.
The study was led by Sheena Reilly of the Murdoch Childrens Research Institute in Parkville. She concluded that parents of children who stutter should not be worried, “Stuttering onset is relatively common but parents can be reassured that developmental stuttering is not associated with poorer outcome in the preschool years at least.”
The study was conducted using 1,600 children from Melbourne, Australia. The researchers asked the mothers of the children to answer questions concerning their babies from since they were eight months old. The children were then assessed based on language and behavior scale. Speech pathologists identified children with stuttering. Overall, children who stutter scored 2.6 points higher than non-stuttering children on non verbal intelligence. Moreover, the researchers concluded that stuttering may in fact be a sign of advanced or improved language skills. The researchers added that “This is a period in which a child’s motor speech system is challenged to keep pace with the phenomenal rate of language acquisition.” As such, children who stutter try to keep up with the pace.
The study is very helpful in understanding the connection between stuttering and mental development, particularly when it comes to language skills and acquisition. Moreover, it aims to help children who suffer from the stigma of stuttering.
It may be too good to be true but that is what the new obesity drug promises. Overweight and obese patients can eat as much as they want without gaining weight because the drug makes the body produce less fat. At the same time, the drug also burns off excess fat from the body. With this new drug, there is no need for anyone to go on a diet and to engage in regular exercise just to lose weight.
The new drug by a private US company Zafgen Inc. targets the body. It changes the composition of the body so that one can remain healthy and not produce fats. Unlike the other dieting drugs or weight loss drugs, this new drugs do not require patients to control what they eat. Although the drug is not yet released on the market, Zafgen sees that there will be no problem with approval. According to the company, the drug is safe so far. The company sees no major concern so far.
The medical implication of this new drug is also very significant. People can remain healthy because their body will not produce fats. Moreover, the drug is very different from the anti obesity drugs that are available today. The anti obesity drugs attack parts of the hypothalamus. This is the area of the brain that affects the appetitie of the individual. This is also the area of the brain that is responsible for happiness. Depression is therefore one of the side effects of anti obesity drugs. This is not the case with the new drugs from Zafgen Inc.